Probiotic lactobacillus casei and lactobacillus paracasei strains in treatment of food allergy in children;Probiotyczne szczepy lactobacillus casei i lactobacillus paracasei w leczeniu alergii pokarmowej u dzieci

Przeglad Pediatryczny

Volumn 40, Issue 1, 2010, Pages 21-25

  Cukrowska, Bozena ^a   Ceregra, Aldona ^a   Klewicka, Elzbieta ^b   Ślizewska, Katarzyna ^b   Motyl, Ilona ^b   Libudzisz, Zdzisława ^b  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b Zakład Mikrobiologii Technicznej Politechniki ŁÓ dzkiej ^*  (Poland)

Author keywords

Atopic eczema; Cow's milk protein allergy; Lactobacillus casei; Lactobacillus paracasei; Probiotics

Indexed keywords

IMMUNOGLOBULIN E; MILK PROTEIN; PLACEBO; PROBIOTIC AGENT;

ARTICLE; ATOPIC DERMATITIS; BACTERIAL STRAIN; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOOD ALLERGY; HUMAN; INFANT; LACTOBACILLUS CASEI; LACTOBACILLUS CASEI LOCK 0900; LACTOBACILLUS CASEI LOCK 0908; LACTOBACILLUS PARACASEI; LACTOBACILLUS PARACASEII LOCK 0910; MAJOR CLINICAL STUDY; MALE; MILK ALLERGY; RANDOMIZED CONTROLLED TRIAL;

EID: 77956408925     PISSN: 0137723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Isolauri E.: Probiotics in human disease. Am. J. Clin. Nutr., 2001, 73, 1142S-1146S.
2. Kalliomaki M., Salminen S., Arvilommi H., Koro P., Koskinen P., Isolauri E.: Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet, 2001, 357, 1076-1079.
3. Kukkonen K., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., Kuitunen M.: Probiotics and prebiotic galacto- oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol., 2007, 119,192-198.
4. Isolauri E., Arvola T., Sutas Y., Maikanen E., Salminen S.: Probiotics in management of atopic eczema. Clin. Exp. Allergy, 2000, 30, 1604-1610.
5. Brouwer M.L., Wolt-Plompen S.A., Dubois A.E., van der Heide S., Jansen D.F., Hoijer M.A., Kauffman H.F., Duiverman EJ.: No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trials. Clin. Exp. Allergy., 2006, 36, 899-906.
6. Gruber C., Wendt M., Sulser C., Lau S., Kulig M., Wahn U., Werfel T., Niggemann B.: Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy, 2007, 62, 1270-1276.
7. Kopp M.V., Hennemuth I., Heinzmann A., Urbanek R.: Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics, 2008, 121, e850-e856.
8. Cukrowska B., Motyl I., Kozakova H., Schwarzer M., Górecki R.K., Klewicka E., Śliżewska K., Libudzisz Z.: Probiotic Lactobacillus strains: in vitro and in vivo studies. Folia Microbiol., 2009, 54, 533-537.
9. Cukrowska B., Ceregra A., Rosiak I., Klewicka E., Śliżewska K., Motyl I., Libudzisz Z.: Wpływ probiotycznych szczepów Lactobacillus casei/ paracasei na przebieg kliniczny wyprysku atopowego i układ immunologiczny u dzieci z alergia̧ pokarmowa̧ na białka mleka krowiego. Pediatr. Współcz., 2008, 10, 15-18.
10. Hanifin J.M., Rajka G.: Diagnostic features of atopic dermatitis. Acta Dermatovener., 1980, 92, 44-47.
11. Pucci N., Novembre E., Cammarata M.G., Bernardini R., Monaco M.G., Calogero C., Vierucci A.: Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index. Allergy., 2005, 60, 113-116.
12. Kalliomäki M., Salminen S., Poussa T., Arvilommi H., Isolauri R.: Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo-controlled trial. Lancet, 2003, 361, 1869-1871.
13. Kalliomäki M., Salminen S., Poussa T., Isolauri E.: Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J. Allergy Clin. Immunol., 2007, 119, 1019-1021.
14. Taylor A.L., Dunstan J.A., Prescott S.L.: Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. J. Allergy Clin. Immunol., 2007, 119, 184-191.
15. Cukrowska B., Rosiak I., Ceregra A., Freszel J., Zakrzewska G., Klewicka E., Motyl I., Libudzisz Z.: Humoral nad cytokine responses induced by probiotic Lactobacillus casei and paracasei strains in children with atopic dermatitis. Ann. Diagn. Paediatr. Pathol., 2006, 10, 115-119.